These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8583979

  • 1. [MDMA--"ecstasy"].
    Keup W.
    Med Monatsschr Pharm; 1996 Jan; 19(1):2-5. PubMed ID: 8583979
    [No Abstract] [Full Text] [Related]

  • 2. Club drug use in Germany.
    Soellner R.
    Subst Use Misuse; 2005 Jan; 40(9-10):1279-93. PubMed ID: 16048817
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E, Hermle L, Kovar KA, Sass H.
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract] [Full Text] [Related]

  • 6. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A.
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of ecstasy on the body].
    Saarijärvi S, Lopperi M.
    Duodecim; 2003 Mar; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract] [Full Text] [Related]

  • 8. The agony of ecstasy: responding to growing MDMA use among college students.
    Walters ST, Foy BD, Castro RJ.
    J Am Coll Health; 2002 Nov; 51(3):139-41. PubMed ID: 12638995
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P, Wittchen HU, Waszak F, Nocon A, Höfler M, Lieb R.
    Drug Alcohol Depend; 2005 Sep 01; 79(3):331-41. PubMed ID: 15913921
    [Abstract] [Full Text] [Related]

  • 11. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
    Bango J, Fadón P, Mata F, Rubio G, Santo-Domingo J.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Sep 01; 26(4):260-3. PubMed ID: 9807860
    [Abstract] [Full Text] [Related]

  • 12. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G, Løvåsdal Ø, Titze TK, Bramness JG, Bachs L.
    Tidsskr Nor Laegeforen; 2006 Feb 23; 126(5):596-8. PubMed ID: 16505868
    [Abstract] [Full Text] [Related]

  • 13. Plasma amino acids in ecstasy users.
    Stuerenburg HJ, Petersen K, Buhmann C, Rosenkranz M, Baeumer T, Thomasius R.
    Neuro Endocrinol Lett; 2003 Oct 23; 24(5):348-9. PubMed ID: 14647011
    [Abstract] [Full Text] [Related]

  • 14. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN, Spigset O, Slørdal L.
    Basic Clin Pharmacol Toxicol; 2008 Jan 23; 102(1):15-24. PubMed ID: 18047478
    [Abstract] [Full Text] [Related]

  • 15. Ecstasy (MDMA) and oral health.
    Brand HS, Dun SN, Nieuw Amerongen AV.
    Br Dent J; 2008 Jan 26; 204(2):77-81. PubMed ID: 18268544
    [Abstract] [Full Text] [Related]

  • 16. [Toxicity of ecstasy].
    Mas M, Farré M, Roset PN, Camí J.
    Med Clin (Barc); 1998 Oct 24; 111(13):516-7. PubMed ID: 9859071
    [No Abstract] [Full Text] [Related]

  • 17. [Psychological aspects of MDMA (ecstasy) users].
    Varescon I.
    Ann Med Interne (Paris); 2003 Nov 24; 154 Spec No 2():S81-5. PubMed ID: 14760230
    [Abstract] [Full Text] [Related]

  • 18. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2006 Mar 24; 101(3):348-61. PubMed ID: 16499508
    [Abstract] [Full Text] [Related]

  • 19. Methodological problems with ecstasy and the SCL-90.
    Cole JC, Sumnall HR, Wagstaff GF.
    Psychopharmacology (Berl); 2002 Jul 24; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
    [No Abstract] [Full Text] [Related]

  • 20. [Ecstasy: idiosyncrasy, overdosage or collateral effects].
    Avila de Tomás JF.
    Med Clin (Barc); 1998 Oct 24; 111(13):517-8. PubMed ID: 9859072
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.